HeartSciences (HSCS) EBT (2021 - 2026)
HeartSciences (HSCS) posted quarterly EBT of -$2.8 million for Q2 2026, down 31.57% year-on-year from -$4.0 million in Q2 2025, and down 17.5% on a QoQ basis from -$2.4 million in Q4 2025.
HeartSciences (HSCS) EBT (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported EBT for 6 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.
- Quarterly EBT fell 31.57% year-over-year to -$2.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$24.6 million (up 51.66% YoY) and the FY2026 annual result came in at -$25.8 million, down 10.19% from the prior year.
- EBT retreated to -$2.8 million in Q2 2026 per HSCS's latest filing, from -$2.4 million in the prior quarter.
- Over the last five years, EBT for HSCS reached as high as -$1.2 million in Q1 2022 and fell as low as -$17.3 million in Q3 2025.
- A 5-year average of -$9.3 million and a median of -$12.4 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT tumbled 1476.03% — and 2025, when it soared 85.34%.
- Year by year, EBT stood at -$12.5 million in 2022, then dropped by 11.23% to -$14.0 million in 2023, then retreated by 15.02% to -$16.0 million in 2024, then surged by 85.34% to -$2.4 million in 2025, then slipped by 17.5% to -$2.8 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$2.8 million, -$2.4 million, and -$17.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2.76 Mn |
| Oct 31, 2025 | -2.35 Mn |
| Jul 31, 2025 | -17.34 Mn |
| Apr 30, 2025 | -2.10 Mn |
| Jan 31, 2025 | -16.96 Mn |
| Oct 31, 2024 | -16.05 Mn |
| Jul 31, 2024 | -15.68 Mn |
| Apr 30, 2024 | -1.90 Mn |
| Jan 31, 2024 | -14.30 Mn |
| Oct 31, 2023 | -13.95 Mn |
| Jul 31, 2023 | -13.35 Mn |
| Apr 30, 2023 | -1.63 Mn |
| Jan 31, 2023 | -12.43 Mn |
| Oct 31, 2022 | -12.54 Mn |
| Jul 31, 2022 | -11.85 Mn |
| Apr 30, 2022 | -2.05 Mn |
| Jan 31, 2022 | -1.24 Mn |
| Oct 31, 2021 | -1.03 Mn |
| Jul 31, 2021 | -752,051.00 |